Can therapy safely be reduced to 2 years for males with pediatric T-cell leukemia?
1 Answers
Mednet Member
Pediatric Hematology/Oncology · Washington University School of Medicine
It is an open research question and it cannot be assumed that T cell ALL would have the same outcome. Given that the salvage rate for relapse T cell ALL is so low, this should be addressed in a clinical trial.